Oral Oncology
Volume 39, Issue 5 , Pages 436-444 , July 2003

A non-invasive technique for studying oral epithelial Epstein–Barr virus infection and disease

  • Dennis M. Walling

      Affiliations

    • Division of Infectious Diseases, Department of Internal Medicine, University of Texas Medical Branch at Galveston, 301 University Boulevard, Galveston, TX 77555-0435, USA
    • Department of Microbiology and Immunology, University of Texas Medical Branch at Galveston, 301 University Boulevard, Galveston, TX 77555-0435, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-409-747-2361; fax: +1-409-772-6527
    • ,
  • Catherine M. Flaitz

      Affiliations

    • Department of Diagnostic Sciences, Oral and Maxillofacial Pathology, University of Texas Health Science Center at Houston, Dental Branch, PO Box 20068, 6516 MD Anderson Boulevard, Houston, TX 77225-0068, USA
    • ,
  • Karen Adler-Storthz

      Affiliations

    • Department of Basic Sciences, University of Texas Health Science Center at Houston, Dental Branch, PO Box 20068, 6516 MD Anderson Boulevard, Houston, TX 77225-0068, USA
    • ,
  • C.Mark Nichols

      Affiliations

    • Bering-Omega Dental Clinic, 1427 Hawthorne, Houston, TX 77006, USA

Received 21 November 2002 ,Accepted 18 December 2002.

References 

  1. Gratama JW, Oosterveer MA, Zwaan FE, Lepoutre J, Klein G, Ernberg I. Eradication of Epstein–Barr virus by allogeneic bone marrow transplantation (implications for sites of viral latency). Proceedings of the National Academy of Sciences of the United States of America. 1988;85:8693–8696
  2. Miller G, Niederman JC, Andrews LL. Prolonged oropharyngeal excretion of Epstein–Barr virus after infectious mononucleosis. New England Journal of Medicine. 1973;288:229–232
  3. Reichart PA, Langford A, Gelderblom HR, Pohle HD, Becker J, Wolf H. Oral hairy leukoplakia (observations in 95 cases and review of the literature). Journal of Oral Pathology and Medicine. 1989;18:410–415
  4. Syrjanen S, Laine P, Niemela M, Happonen RP. Oral hairy leukoplakia is not a specific sign of HIV-infection but related to immunosuppression in general. Journal of Oral Pathology and Medicine. 1989;18:28–31
  5. Lozada-Nur F, Robinson J, Regezi JA. Oral hairy leukoplakia in nonimmunosuppressed patients. Report of four cases. Oral Surgery, Oral Medicine, Oral Pathology. 1994;78:599–602
  6. Greenspan JS, Greenspan D. Oral hairy leukoplakia (diagnosis and management). Oral Surgery, Oral Medicine, Oral Pathology. 1989;67:396–403
  7. Greenspan JS, De Souza YG, Regezi JA, Daniels TE, Greenspan D, MacPhail LA, et al.  Comparison of cytopathic changes in oral hairy leukoplakia with in situ hybridization for EBV DNA. Oral Diseases. 1998;4:95–99
  8. Greenspan JS, Greenspan D, Lennette ET, Abrams DI, Conant MA, Petersen V, et al.  Replication of Epstein–Barr virus within the epithelial cells of oral “hairy” leukoplakia, an AIDS-associated lesion. New England Journal of Medicine. 1985;313:1564–1571
  9. Walling DM, Flaitz CM, Nichols CM, Hudnall SD, Storthz KA. Persistent productive Epstein–Barr virus replication in normal tongue epithelial cells in vivo. Journal of Infectious Diseases. 2001;184:1499–1507
  10. Webster-Cyriaque J, Middeldorp J, Raab-Traub N. Hairy leukoplakia (an unusual combination of transforming and permissive Epstein–Barr virus infections). Journal of Virology. 2000;74:7610–7618
  11. Niedobitek G. Epstein–Barr virus infection in the pathogenesis of nasopharyngeal carcinoma. Molecular Pathology. 2000;53:248–254
  12. Thomas DW, Ramsahoye B, Jasani B, Lim SH. Epstein–Barr virus in squamous cell carcinoma after renal transplantation. Transplantation. 1995;60:390–392
  13. Niedobitek G, Young LS, Lau R, Brooks L, Greenspan D, Greenspan JS, et al.  Epstein–Barr virus infection in oral hairy leukoplakia (virus replication in the absence of a detectable latent phase). Journal of General Virology. 1991;72:3035–3046
  14. De Souza YG, Freese UK, Greenspan D, Greenspan JS. Diagnosis of Epstein–Barr virus infection in hairy leukoplakia by using nucleic acid hybridization and noninvasive techniques. Journal of Clinical Microbiology. 1990;28:2775–2778
  15. Naher H, Gissmann L, von Knebel Doeberitz C, von Knebel Doeberitz M, Greenspan JS, Greenspan D, et al.  Detection of Epstein–Barr virus-DNA in tongue epithelium of human immunodeficiency virus-infected patients. Journal of Investigative Dermatology. 1991;97:421–424
  16. Fraga-Fernandez J, Vicandi-Plaza B. Diagnosis of hairy leukoplakia by exfoliative cytologic methods. American Journal of Clinical Pathology. 1992;97:262–266
  17. Migliorati CA, Jones AC, Baughman PA. Use of exfoliative cytology in the diagnosis of oral hairy leukoplakia. Oral Surgery, Oral Medicine, Oral Pathology. 1993;76:704–710
  18. Itin PH, Bircher AJ, Litzisdorf Y, Rudin C. Oral hairy leukoplakia in a child (confirmation of the clinical diagnosis by ultrastructural examination of exfoliative cytologic specimens). Dermatology. 1994;189:167–169
  19. Epstein JB, Fatahzadeh M, Matisic J, Anderson G. Exfoliative cytology and electron microscopy in the diagnosis of hairy leukoplakia. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics. 1995;79:564–569
  20. Scully C, Porter SR, Di Alberti L, Jalal M, Maitland N. Detection of Epstein–Barr virus in oral scrapes in HIV infection, in hairy leukoplakia, and in healthy non-HIV-infected people. Journal of Oral Pathology and Medicine. 1998;27:480–482
  21. Webster-Cyriaque J, Middeldorp J, Raab-Traub N. Hairy leukoplakia (an unusual combination of transforming and permissive Epstein–Barr virus infections). Journal of Virology. 2000;74:7610–7618
  22. Walling DM, Edmiston SN, Sixbey JW, Abdel-Hamid M, Resnick L, Raab-Traub N. Coinfection with multiple strains of the Epstein–Barr virus in human immunodeficiency virus-associated hairy leukoplakia. Proceedings of the National Academy of Sciences of the United States of America. 1992;89:6560–6564
  23. Walling DM, Shebib N, Weaver SC, Nichols CM, Flaitz CM, Webster-Cyriaque J. The molecular epidemiology and evolution of Epstein–Barr virus (sequence variation and genetic recombination in the latent membrane protein-1 gene). Journal of Infectious Diseases. 1999;179:763–774
  24. Walling DM, Perkins AG, Webster-Cyriaque J, Resnick L, Raab-Traub N. The Epstein–Barr virus EBNA-2 gene in oral hairy leukoplakia (strain variation, genetic recombination, and transcriptional expression). Journal of Virology. 1994;68:7918–7926
  25. Walling DM, Raab-Traub N. Epstein–Barr virus intrastrain recombination in oral hairy leukoplakia. Journal of Virology. 1994;68:7909–7917
  26. Sixbey JW, Shirley P, Sloas M, Raab-Traub N, Israele V. A transformation-incompetent, nuclear antigen 2-deleted Epstein–Barr virus associated with replicative infection. Journal of Infectious Diseases. 1991;163:1008–1015
  27. Walling DM, Clark NM, Markovitz DM, Frank TS, Braun DK, Eisenberg E, et al.  Epstein–Barr virus coinfection and recombination in non-human immunodeficiency virus-associated oral hairy leukoplakia [see comments]. Journal of Infectious Diseases. 1995;171:1122–1130
  28. Sciubba JJ  U.S. collaborative OralCDx study group. Improving detection of precancerous and cancerous oral lesions. Computer-assisted analysis of the oral brush biopsy. Journal of the American Dental Association. 1999;130:1445–1457
  29. Christian DC. Computer-assisted analysis of oral brush biopsies at an oral cancer screening program. Journal of the American Dental Association. 2002;133:357–362
  30. Mabruk MJ, Flint SR, Toner M, Balluz I, Coleman D, Sullivan D, et al.  In situ hybridization and the polymerase chain reaction (PCR) in the analysis of biopsies and exfoliative cytology specimens for definitive diagnosis of oral hairy leukoplakia (OHL). Journal of Oral Pathology and Medicine. 1994;23:302–308

☆ This work was presented in part at the Tenth Biennial Meeting of the International Association for Research on Epstein–Barr Virus and Associated Diseases, Cairns, Australia, July 2002. Informed consent was obtained from each research subject participating in this research. The human experimentation guidelines of each participating institution were followed in the conduct of this research.

PII: S1368-8375(03)00002-2

doi: 10.1016/S1368-8375(03)00002-2

Oral Oncology
Volume 39, Issue 5 , Pages 436-444 , July 2003

Article Tools

* Image Usage & Resolution